| Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements V Aggarwal, HS Tuli, A Varol, F Thakral, MB Yerer, K Sak, M Varol, A Jain, ... Biomolecules 9 (11), 735, 2019 | 774 | 2019 |
| Molecular mechanisms of action of genistein in cancer: Recent advances HS Tuli, MJ Tuorkey, F Thakral, K Sak, M Kumar, AK Sharma, U Sharma, ... Frontiers in Pharmacology 10, 1336, 2019 | 232 | 2019 |
| Fisetin and quercetin: promising flavonoids with chemopreventive potential D Kashyap, VK Garg, HS Tuli, MB Yerer, K Sak, AK Sharma, M Kumar, ... Biomolecules 9 (5), 174, 2019 | 166 | 2019 |
| Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements V Aggarwal, HS Tuli, F Thakral, P Singhal, D Aggarwal, S Srivastava, ... Experimental Biology and Medicine 245 (5), 486-497, 2020 | 117 | 2020 |
| Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement V Aggarwal, HS Tuli, M Tania, S Srivastava, EE Ritzer, A Pandey, ... Seminars in cancer biology 80, 256-275, 2022 | 98 | 2022 |
| Molecular mechanisms of action of tocotrienols in cancer: Recent trends and advancements V Aggarwal, D Kashyap, K Sak, HS Tuli, A Jain, A Chaudhary, VK Garg, ... International journal of molecular sciences 20 (3), 656, 2019 | 91 | 2019 |
| Baicalein: A metabolite with promising antineoplastic activity HS Tuli, V Aggarwal, J Kaur, D Aggarwal, G Parashar, NC Parashar, ... Life Sciences 259, 118183, 2020 | 53 | 2020 |
| Interplay between tumor microenvironment and partial EMT as the driver of tumor progression V Aggarwal, CA Montoya, VS Donnenberg, S Sant IScience 24 (2), 2021 | 51 | 2021 |
| Emergence of circulating MicroRNAs in breast cancer as diagnostic and therapeutic efficacy biomarkers V Aggarwal, K Priyanka, HS Tuli Molecular diagnosis & therapy 24 (2), 153-173, 2020 | 50 | 2020 |
| Recent advances in elucidating the genetics of common variable immunodeficiency V Aggarwal, AZ Banday, AK Jindal, J Das, A Rawat Genes & diseases 7 (1), 26-37, 2020 | 45 | 2020 |
| Garcinol exhibits anti-neoplastic effects by targeting diverse oncogenic factors in tumor cells V Aggarwal, HS Tuli, J Kaur, D Aggarwal, G Parashar, ... Biomedicines 8 (5), 103, 2020 | 43 | 2020 |
| COVID-19 pandemic: from molecular biology, pathogenesis, detection, and treatment to global societal impact S Sood, V Aggarwal, D Aggarwal, SK Upadhyay, K Sak, HS Tuli, M Kumar, ... Current pharmacology reports 6, 212-227, 2020 | 38 | 2020 |
| Leukocyte adhesion defect: Where do we stand circa 2019? J Das, A Sharma, A Jindal, V Aggarwal, A Rawat Genes & Diseases 7 (1), 107-114, 2020 | 36 | 2020 |
| Clinical, immunological, and molecular profile of chronic granulomatous disease: a multi-centric study of 236 patients from India A Rawat, P Vignesh, M Sudhakar, M Sharma, D Suri, A Jindal, A Gupta, ... Frontiers in immunology 12, 625320, 2021 | 30 | 2021 |
| Role of reactive oxygen species in cancer progression: Molecular mechanisms and recent advancements. Biomolecules 9, 735 V Aggarwal, HS Tuli, A Varol, F Thakral, MB Yerer, K Sak, M Varol, A Jain, ... | 25 | 2019 |
| Three dimensional engineered models to study hypoxia biology in breast cancer V Aggarwal, O Miranda, PA Johnston, S Sant Cancer letters 490, 124-142, 2020 | 21 | 2020 |
| NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target V Aggarwal, HS Tuli, M Varol, M Tuorkey, K Sak, NC Parashar, TS Barwal, ... Critical Reviews in Oncology/Hematology 164, 103403, 2021 | 16 | 2021 |
| Deguelin targets multiple oncogenic signaling pathways to combat human malignancies HS Tuli, S Mittal, M Loka, V Aggarwal, D Aggarwal, A Masurkar, G Kaur, ... Pharmacological Research 166, 105487, 2021 | 16 | 2021 |
| MYD88, CARD11, and CD79B oncogenic mutations are rare events in the indian cohort of de novo nodal diffuse large B-cell lymphoma V Aggarwal, A Das, A Bal, R Srinivasan, R Das, G Prakash, P Malhotra, ... Applied Immunohistochemistry & Molecular Morphology 27 (4), 311-318, 2019 | 13 | 2019 |
| Emodin: A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets HS Tuli, V Aggarwal, M Tuorkey, D Aggarwal, NC Parashar, M Varol, ... Toxicology in Vitro 73, 105142, 2021 | 10 | 2021 |
